MedPath

Role Ayurveda in Thalassemia

Phase 3
Completed
Conditions
Health Condition 1: D561- Beta thalassemia
Registration Number
CTRI/2021/12/038450
Lead Sponsor
Institite of Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Diagnosed cases of Thalassemia Major

Age group: 02-12 years of either sex

Exclusion Criteria

Children below age 2 year and above 12 years of either sex.

Patients having HIV, HBV infection, Hepatic failure, DM, TB.

Patients having BT interval of less than 12 days.

Patients who have undergone splenectomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the Blood Transfusion Interval, Hb% and S. TIBC.Timepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
Changes in sign and symptoms which are associated with Thalassemia Major (Pandu) and all other parameters.Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath